ABVC BioPharma, Inc. (ABVC) Total Return Calculator with Dividends Reinvested

ABVC BioPharma, Inc.

Popular:

The total return for ABVC BioPharma, Inc. (ABVC) stock is -35.44% over the past 12 months. So far it's down 39.27% this year. The 5-year total return is -97.34%, meaning $10,000 invested in ABVC stock 5 years ago would be worth $266 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ABVC 1 year ago, it would be worth $6,892 today — you'd have lost $3,108.

With Dividends Reinvested$6,892-31.08%

Price Only (No DRIP)$6,892-31.08%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ABVC

1Y$6,456-$3,544 (-35.4%)-35.4% CAGR

3Y$2,337-$7,663 (-76.6%)-38.4% CAGR

5Y$266-$9,734 (-97.3%)-51.6% CAGR

10Y$37-$9,963 (-99.6%)-42.9% CAGR

15Y$0-$10,000 (-100.0%)-48.6% CAGR

20Y$0-$10,000 (-100.0%)-49.9% CAGR

30Y$0-$10,000 (-100.0%)-33.9% CAGR

ABVC BioPharma, Inc. did not pay dividends during this period. Total return = price return.

Loading ABVC total return...

As of 2026-06-28

Performance Summary

Best Year+232.29%2025

Worst Year-94.44%2012

Max Drawdown-80.81%2025-07-08 → 2026-03-30

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-39.27%	—	-30.14%	—	$6,073
1Y	-35.44%	-35.44%	-30.14%	—	$6,456
3Y	-76.63%	-38.40%	-73.11%	—	$2,337
5Y	-97.34%	-51.59%	-96.94%	—	$266
10Y	-99.63%	-42.89%	-99.57%	—	$37
15Y	-100.00%	-48.61%	-99.99%	—	$0
20Y	-100.00%	-49.88%	-100.00%	—	$0
30Y	-100.00%	-33.92%	-100.00%	—	$0

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-40.18%	-40.18%	—	+0.41%	-40.6pp
2025	+232.29%	+232.29%	—	+16.64%	+215.7pp
2024	-50.83%	-50.83%	—	+24.00%	-74.8pp
2023	-80.67%	-80.67%	—	+24.81%	-105.5pp
2022	-81.34%	-81.34%	—	-19.95%	-61.4pp

ABVC underperformed the S&P 500 by 56.28pp over the past year (-35.44% vs +20.84%).

Loading summary...

ABVC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ABVCABVC BioPharma, Inc.	$22M	+21.4%	-39.3%	-35.4%	—	-76.6%	-97.3%	-99.6%
ATHAAthira Pharma, Inc.	$17M	—	-37.6%	+45.6%	—	-85.6%	-96.1%	-97.5%
SAVACassava Sciences, Inc.	$64M	—	-36.8%	-32.0%	—	-60.8%	-88.7%	-35.0%
NRXPNRx Pharmaceuticals, Inc.	$64M	-13.5%	+36.3%	+10.9%	—	-28.6%	-97.4%	-96.3%
INVAInnoviva, Inc.	$1.7B	+3.9%	+19.0%	+14.3%	—	+87.0%	+75.6%	+129.1%
AYTUAytu BioPharma, Inc.	$18M	-0.5%	-20.9%	+7.4%	—	+37.7%	-98.0%	-100.0%
HROWHarrow Health, Inc.	$1.6B	+23.1%	-14.5%	+34.6%	—	+137.0%	+309.2%	+972.4%
PRAXPraxis Precision Medicines, Inc.	$9.5B	-6.5%	+7.9%	+602.8%	—	+1824.9%	+5.4%	-25.9%
IQVIQVIA Holdings Inc.	$32.4B	+18.0%	-17.6%	+17.1%	—	-13.2%	-22.9%	+193.1%
CRLCharles River Laboratories International, Inc.	$10.4B	+37.7%	-0.2%	+36.2%	—	-2.0%	-44.9%	+151.5%
MEDPMedpace Holdings, Inc.	$15.1B	+22.8%	-10.2%	+62.6%	—	+127.8%	+188.1%	+1745.2%

Compare:ABVC vs ATHA ABVC vs SAVA ABVC vs NRXP ABVC vs ATHA vs SAVA

About ABVC Dividend Returns

ABVC BioPharma, Inc. (ABVC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ABVC over the past year?

ABVC BioPharma, Inc. (ABVC) delivered a return of -35.44% over the past year. Since ABVC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ABVC be worth today?

A $10,000 investment in ABVC BioPharma, Inc. one year ago would be worth $6,456 today, representing a loss of $3,544.

Q3Does ABVC pay dividends?

ABVC BioPharma, Inc. (ABVC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ABVC, the total return equals the price-only return.

Q4Did ABVC beat the S&P 500?

No, ABVC BioPharma, Inc. (ABVC) underperformed the S&P 500 by 56.28 percentage points over the past year. ABVC delivered a total return of -35.44%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed ABVC by 56.28pp during this period.

Q5What is ABVC's worst drawdown?

ABVC BioPharma, Inc. (ABVC) experienced a maximum drawdown of -80.81% over the past year, declining from its peak on 2025-07-08 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ABVC's long-term total return over 10, 20, or 30 years?

Here are ABVC BioPharma, Inc. (ABVC)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.6% (-42.9% CAGR) — $10,000 would have grown to $37. Over 20 years: -100.0% total return (-49.9% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-33.9% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ABVC's best and worst year?

ABVC BioPharma, Inc.'s best calendar year was 2025 with a total return of 232.3%. Its worst year was 2012 with a total return of -94.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 326.7 percentage points.

How much would $100/month in ABVC be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →